Dermatitis, Allergic Contact
7
0
0
5
Key Insights
Highlights
Success Rate
83% trial completion
Treatment Research
9 treatments under study, led by Rhuph20
Research Leaders
9 sponsors active, led by Smart Practice
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 47/100
14.3%
1 terminated out of 7 trials
83.3%
+68.3% vs benchmark
0%
0 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Based on 5 completed trials
Clinical Trials (7)
Clinical Observations of Pain and Pruritus Induced by Exposure to Allergic Contact Dermatitis Caused by Macrolides
Incidence of Allergic Manifestations and Infectious Episodes in Healthy Term Infants at Risk for Dysbiosis
Study of the Intradermal Injection of rHuPH20 or Placebo in Participants With Nickel Allergic Contact Dermatitis
Cutaneous and Systemic Reactions to Metal Implants
NeoMatriX Wound Matrix Collagen Dressing Skin Prick Test
Intervention Study to Evaluate the Importance of Information Given to Patients With Contact Allergy
CP-481,715 Nickel Allergy Study.
Research Network
Common Treatments
- Rhuph201
- Neomatrix Wound Matrix Collagen Dressing1
- Cp4817151
- Infant Formula1
- Azithromycin1
Active Sponsors
- Smart Practice1
- NYU Langone Health1
- State University of New York at Buffalo1
- Pfizer1
- Region Skane1
Top Investigators
Scientific Committee
Scientific Committee
Saint Anthony Memorial Research Center
Region Skåne, Hudkliniken SUS
Scientific Committee
Related Conditions
- Allergy1
- Infectious Diseases1
- Allergy Skin1